Cargando…
Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer’s disease: a cohort study
BACKGROUND: Alzheimer’s disease is characterized by aggregated β-amyloid and tau proteins, but the clinical presentations and patterns of brain atrophy vary substantially. A part of this heterogeneity may be linked to the risk allele APOE ε4. The spread of tau pathology is related to atrophy and cog...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081879/ https://www.ncbi.nlm.nih.gov/pubmed/30086796 http://dx.doi.org/10.1186/s13195-018-0403-x |
_version_ | 1783345728217677824 |
---|---|
author | Mattsson, Niklas Ossenkoppele, Rik Smith, Ruben Strandberg, Olof Ohlsson, Tomas Jögi, Jonas Palmqvist, Sebastian Stomrud, Erik Hansson, Oskar |
author_facet | Mattsson, Niklas Ossenkoppele, Rik Smith, Ruben Strandberg, Olof Ohlsson, Tomas Jögi, Jonas Palmqvist, Sebastian Stomrud, Erik Hansson, Oskar |
author_sort | Mattsson, Niklas |
collection | PubMed |
description | BACKGROUND: Alzheimer’s disease is characterized by aggregated β-amyloid and tau proteins, but the clinical presentations and patterns of brain atrophy vary substantially. A part of this heterogeneity may be linked to the risk allele APOE ε4. The spread of tau pathology is related to atrophy and cognitive decline, but little data exist on the effects of APOE ε4 on tau. The objective of this preliminary study was therefore to test if tau load and brain structure differ by APOE ε4 in Alzheimer’s disease. METHODS: Sixty-five β-amyloid-positive patients at the prodromal and dementia stages of Alzheimer’s disease were enrolled, including APOE ε4-positive (n = 46) and APOE ε4-negative (n = 19) patients. (18)F-AV-1451 positron emission tomography was used to measure tau and brain magnetic resonance imaging (MRI) was used to measure cortical thickness. RESULTS: Compared with their APOE ε4-positive counterparts, APOE ε4-negative patients had greater tau load and reduced cortical thickness, with the most pronounced effects for both in the parietal cortex. Relative to the overall cortical tau load, APOE ε4-positive patients had greater tau load in the entorhinal cortex. APOE ε4-positive patients also had slightly greater cortical β-amyloid load. There was an interaction between APOE ε4 and (18)F-AV-1451 on cortical thickness, with greater effects of (18)F-AV-1451 on cortical thickness in APOE ε4-negative patients. APOE ε4 and (18)F-AV-1451 were independent predictors of cognition, but showed distinct associations with different cognitive tests. CONCLUSIONS: APOE genotype may be associated with differences in pathways in Alzheimer’s disease, potentially through differential development and spread of tau, as well as through effects on cognitive outcomes involving non-tau-related mechanisms. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13195-018-0403-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6081879 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60818792018-08-10 Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer’s disease: a cohort study Mattsson, Niklas Ossenkoppele, Rik Smith, Ruben Strandberg, Olof Ohlsson, Tomas Jögi, Jonas Palmqvist, Sebastian Stomrud, Erik Hansson, Oskar Alzheimers Res Ther Research BACKGROUND: Alzheimer’s disease is characterized by aggregated β-amyloid and tau proteins, but the clinical presentations and patterns of brain atrophy vary substantially. A part of this heterogeneity may be linked to the risk allele APOE ε4. The spread of tau pathology is related to atrophy and cognitive decline, but little data exist on the effects of APOE ε4 on tau. The objective of this preliminary study was therefore to test if tau load and brain structure differ by APOE ε4 in Alzheimer’s disease. METHODS: Sixty-five β-amyloid-positive patients at the prodromal and dementia stages of Alzheimer’s disease were enrolled, including APOE ε4-positive (n = 46) and APOE ε4-negative (n = 19) patients. (18)F-AV-1451 positron emission tomography was used to measure tau and brain magnetic resonance imaging (MRI) was used to measure cortical thickness. RESULTS: Compared with their APOE ε4-positive counterparts, APOE ε4-negative patients had greater tau load and reduced cortical thickness, with the most pronounced effects for both in the parietal cortex. Relative to the overall cortical tau load, APOE ε4-positive patients had greater tau load in the entorhinal cortex. APOE ε4-positive patients also had slightly greater cortical β-amyloid load. There was an interaction between APOE ε4 and (18)F-AV-1451 on cortical thickness, with greater effects of (18)F-AV-1451 on cortical thickness in APOE ε4-negative patients. APOE ε4 and (18)F-AV-1451 were independent predictors of cognition, but showed distinct associations with different cognitive tests. CONCLUSIONS: APOE genotype may be associated with differences in pathways in Alzheimer’s disease, potentially through differential development and spread of tau, as well as through effects on cognitive outcomes involving non-tau-related mechanisms. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13195-018-0403-x) contains supplementary material, which is available to authorized users. BioMed Central 2018-08-07 /pmc/articles/PMC6081879/ /pubmed/30086796 http://dx.doi.org/10.1186/s13195-018-0403-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Mattsson, Niklas Ossenkoppele, Rik Smith, Ruben Strandberg, Olof Ohlsson, Tomas Jögi, Jonas Palmqvist, Sebastian Stomrud, Erik Hansson, Oskar Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer’s disease: a cohort study |
title | Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer’s disease: a cohort study |
title_full | Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer’s disease: a cohort study |
title_fullStr | Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer’s disease: a cohort study |
title_full_unstemmed | Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer’s disease: a cohort study |
title_short | Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer’s disease: a cohort study |
title_sort | greater tau load and reduced cortical thickness in apoe ε4-negative alzheimer’s disease: a cohort study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081879/ https://www.ncbi.nlm.nih.gov/pubmed/30086796 http://dx.doi.org/10.1186/s13195-018-0403-x |
work_keys_str_mv | AT mattssonniklas greatertauloadandreducedcorticalthicknessinapoee4negativealzheimersdiseaseacohortstudy AT ossenkoppelerik greatertauloadandreducedcorticalthicknessinapoee4negativealzheimersdiseaseacohortstudy AT smithruben greatertauloadandreducedcorticalthicknessinapoee4negativealzheimersdiseaseacohortstudy AT strandbergolof greatertauloadandreducedcorticalthicknessinapoee4negativealzheimersdiseaseacohortstudy AT ohlssontomas greatertauloadandreducedcorticalthicknessinapoee4negativealzheimersdiseaseacohortstudy AT jogijonas greatertauloadandreducedcorticalthicknessinapoee4negativealzheimersdiseaseacohortstudy AT palmqvistsebastian greatertauloadandreducedcorticalthicknessinapoee4negativealzheimersdiseaseacohortstudy AT stomruderik greatertauloadandreducedcorticalthicknessinapoee4negativealzheimersdiseaseacohortstudy AT hanssonoskar greatertauloadandreducedcorticalthicknessinapoee4negativealzheimersdiseaseacohortstudy |